galantamine has been researched along with Symptom Cluster in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujita, Y; Haga, Y; Hanazawa, T; Kamijo, Y; Usui, K; Yoshizawa, T | 1 |
| Chen, CF; Hsu, HC; Lin, YC; Ouyang, WC | 1 |
| Dewailly, P; Gaxatte, C; Huvent-Grelle, D; Puisieux, F; Roche, J | 1 |
| Ihl, R | 1 |
| Adam, MP; Cubells, JF; Deoreo, EH; Garber, K; Garlow, SJ; Harvey, PD; Martin, CL | 1 |
| Catte, O; Cossu, G; Maccioni, E; Melis, G; Melis, M; Putzu, PF; Putzu, V | 1 |
| Flecchia, G | 1 |
| Baraka, A; Harik, S | 1 |
| Avakian, GN; Groppa, SA; Shakhnovich, VA | 1 |
2 review(s) available for galantamine and Symptom Cluster
| Article | Year |
|---|---|
[Relation between Pisa syndrome and choline esterase inhibitors in a cohort of Alzheimer's disease patients].
Topics: Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Cohort Studies; Donepezil; Dystonia; Galantamine; Humans; Indans; Male; Piperidines; Syndrome | 2009 |
[Anti-dementia drugs for dementia syndromes--just unkept promises?].
Topics: Alzheimer Disease; Clinical Trials as Topic; Dopamine Agents; Galantamine; Ginkgo biloba; Humans; Memantine; Meta-Analysis as Topic; Nootropic Agents; Phytotherapy; Plant Preparations; Syndrome | 2006 |
7 other study(ies) available for galantamine and Symptom Cluster
| Article | Year |
|---|---|
Acute cholinergic syndrome in a patient with Alzheimer's disease taking the prescribed dose of galantamine.
Topics: Aged, 80 and over; Alzheimer Disease; Atrophy; Brain; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Galantamine; Humans; Male; Syndrome; Tomography, X-Ray Computed | 2018 |
Galantamine-induced pisa syndrome: memantine as an alternative.
Topics: Aged; Alzheimer Disease; Cholinesterase Inhibitors; Dystonic Disorders; Female; Galantamine; Humans; Memantine; Syndrome | 2008 |
Pharmaco-genetically guided treatment of recurrent rage outbursts in an adult male with 15q13.3 deletion syndrome.
Topics: Adult; Cholinesterase Inhibitors; Chromosome Deletion; Chromosomes, Human, Pair 15; Epilepsy; Female; Galantamine; Humans; Male; Mental Disorders; Pharmacogenetics; Phenotype; Rage; Schizophrenia; Syndrome | 2011 |
Reversible Pisa syndrome (pleurothotonus) due to the cholinesterase inhibitor galantamine: case report.
Topics: Aged; Alzheimer Disease; Botulinum Toxins, Type A; Cholinesterase Inhibitors; Cognition Disorders; Dystonia; Female; Galantamine; Humans; Neuromuscular Agents; Neuropsychological Tests; Severity of Illness Index; Syndrome | 2004 |
[Isolated viral syndrome of the ambiguous nucleus].
Topics: Adult; Aged; Amino Acids; Betamethasone; Deglutition Disorders; Galantamine; Glossopharyngeal Nerve; Humans; Male; Muramidase; Pharyngeal Diseases; Pyrrolidines; Syndrome; Thiamine; Virus Diseases; Vitamin B 12 | 1979 |
Reversal of central anticholinergic syndrome by galanthamine.
Topics: Blood-Brain Barrier; Delirium; Delusions; Galantamine; Hallucinations; Humans; Injections, Intravenous; Male; Scopolamine; Sleep; Syndrome; Wakefulness | 1977 |
[Electrophysiologic analysis of the selectivity of action of anticholinesterase preparations in hereditary ataxias].
Topics: Adolescent; Adult; Aminoquinolines; Brain Stem; Cerebellar Ataxia; Charcot-Marie-Tooth Disease; Child; Cholinesterase Inhibitors; Evoked Potentials, Auditory; Friedreich Ataxia; Galantamine; Humans; Psychomotor Performance; Syndrome | 1986 |